| Prevalence, imaging patterns and risk factors of interstitial lung disease in connective tissue disease: a systematic review and meta-analysis GM Joy, OA Arbiv, CK Wong, SD Lok, NA Adderley, KM Dobosz, ... European Respiratory Review 32 (167), 2023 | 30 | 2023 |
| Inhalational exposures in patients with fibrotic interstitial lung disease: presentation, pulmonary function and survival in the Canadian Registry for Pulmonary Fibrosis CT Lee, ME Strek, A Adegunsoye, AW Wong, D Assayag, G Cox, CD Fell, ... Respirology 27 (8), 635-644, 2022 | 15 | 2022 |
| Prevalence of allergen sensitization in 1000 adults in Saskatchewan SD Lok, BE Davis, DW Cockcroft Allergy, Asthma & Clinical Immunology 13, 1-5, 2017 | 15 | 2017 |
| Eligibility criteria from pharmaceutical randomised controlled trials of idiopathic pulmonary fibrosis: a registry-based study YH Khor, M Schulte, KA Johannson, V Marcoux, JH Fisher, D Assayag, ... European Respiratory Journal 61 (5), 2023 | 7 | 2023 |
| Integration and application of radiologic patterns from clinical practice guidelines on idiopathic pulmonary fibrosis and fibrotic hypersensitivity pneumonitis DC Marinescu, CJ Hague, NL Muller, D Murphy, A Churg, JL Wright, ... Chest 164 (6), 1466-1475, 2023 | 5 | 2023 |
| Trajectories and prognostic significance of 6-minute walk test parameters in fibrotic interstitial lung disease: A multicenter study YH Khor, M Farooqi, N Hambly, KA Johannson, V Marcoux, JH Fisher, ... Chest 163 (2), 345-357, 2023 | 4 | 2023 |
| Clinical relevance of rheumatoid factor and anti‐citrullinated peptides in fibrotic interstitial lung disease B Zheng, K Donohoe, N Hambly, KA Johannson, D Assayag, JH Fisher, ... Respirology 27 (10), 854-862, 2022 | 4 | 2022 |
| Malignancy risk associated with mycophenolate mofetil or azathioprine in patients with fibrotic interstitial lung disease SD Lok, AW Wong, YH Khor, CJ Ryerson, KA Johannson, V Marcoux, ... Chest 161 (6), 1594-1597, 2022 | 4 | 2022 |
| Predicting new-onset exertional and resting hypoxemia in fibrotic interstitial lung disease F Saleem, CJ Ryerson, N Sarma, K Johannson, V Marcoux, J Fisher, ... Annals of the American Thoracic Society 20 (12), 1726-1734, 2023 | 2 | 2023 |
| Prevalence and outcomes of interstitial lung abnormalities in a Canadian lung cancer screening trial K Stuart, M Ahmad, SD Lok, AM Gillson, ELR Bédard, A Tremblay, ... Canadian Journal of Respiratory, Critical Care, and Sleep Medicine 7 (3 …, 2023 | 2 | 2023 |
| Assessment of ratio of peak expiratory flow rate to vital capacity for identifying pulmonary fibrosis SD Lok, DW Cockcroft, A Simidchiev Clinical and Investigative Medicine 44 (1), E25-E27, 2021 | 2 | 2021 |
| Impact of surgical lung biopsy on lung function and survival in patients with idiopathic pulmonary fibrosis in a multi‐centre registry cohort V Marcoux, SD Lok, P Mondal, D Assayag, JH Fisher, S Shapera, ... Respirology, 2024 | 1 | 2024 |
| Characteristics and risk factors of interstitial pneumonia with autoimmune features S Vahidy, J Agyeman, B Zheng, K Donohoe, N Hambly, KA Johannson, ... Respiratory Medicine 221, 107500, 2024 | 1 | 2024 |
| The clinical frailty scale is associated with progression of fibrotic interstitial lung disease–a multicentre cohort study. SA Guler, DC Marinescu, G Cox, C Durand, JH Fisher, A Grant-Orser, ... European Respiratory Journal 62 (suppl 67), 2023 | 1 | 2023 |
| Treatment of rheumatoid arthritis-associated interstitial lung disease in a multi-center registry cohort V Marcoux, S Lok, P Mondal, D Assayag, JH Fisher, S Shapera, ... Journal of Thoracic Disease 15 (5), 2517, 2023 | 1 | 2023 |
| Increasing Honeycombing and Traction Bronchiectasis on Computed Tomography Are Independent Predictors of Survival Across All Interstitial Lung Disease Subtypes D Marinescu, C Hague, N Muller, D Murphy, AM Churg, J Wright, ... D91. LOOKING FOR THE CRYSTAL BALL: BIOMARKERS TO PREDICT DISEASE PROGRESSION …, 2023 | 1 | 2023 |
| Enhancing pulmonary rehabilitation enrollment study (PRESS III) SD Lok, J Marciniuk, M Baranyi, A Hasany, DD Marciniuk Canadian Journal of Respiratory, Critical Care, and Sleep Medicine 5 (1), 38-42, 2021 | 1 | 2021 |
| Organic Exposures, Radiologic Features, and Patterns in Fibrotic Interstitial Lung Disease SD Lok, DC Marinescu, V Marcoux, M Kolb, JH Fisher, SS Shapera, ... Annals of the American Thoracic Society, 2024 | | 2024 |
| The Impact of Frailty on Prescribing Patterns and Medication Tolerability in Patients With Fibrotic Interstitial Lung Disease AW Wong, D Marinescu, GP Cox, C Durand, JH Fisher, A Grant-Orser, ... B48. NEW TREATMENTS IN DIFFUSE PARENCHYMAL LUNG DISEASE, A3740-A3740, 2024 | | 2024 |
| Significance of Cysts in the Diagnosis of Fibrotic Interstitial Lung Disease L Minuk, C Hague, N Muller, D Murphy, AM Churg, JL Wright, ... A46. DIAGNOSIS AND MONITORING OF ILD, A1749-A1749, 2024 | | 2024 |
